Search
Search Results
##search.searchResults.foundPlural##
-
SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib
960PDF: 524HTML: 215 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
2046PDF: 774HTML: 3117 -
THE ROLE OF WHITE BLOOD CELL COUNT IN PERIANAL PATHOLOGIES: A RETROSPECTIVE ANALYSIS OF HEMATOLOGIC MALIGNANCIES Role of white blood cell count in perianal pathologies
3611PDF: 1932HTML: 245 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4115PDF: 1265HTML: 1963Table 1: 204 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1270PDF: 1017HTML: 226 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2202PDF: 1616HTML: 314 -
RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM
1257PDF: 1082HTML: 206 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3590PDF: 2515HTML: 1499 -
THE Co-Occurrence of Jak2/Calr-Positive Myeloproliferative Disorder and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib. Dual Myeloid Disorder Treated with Two Drug Association
1087PDF: 1172HTML: 98 -
Interstitial pneumonia triggered by H1N1 influenza A virus as the initial presentation of chronic myeloid leukemia
895PDF: 498HTML: 153Suppl. Files: 330 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4840PDF: 1797HTML: 2723Untitled: 227 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7661PDF: 2448HTML: 1742Table 1.: 216Table 2.: 226Table 3.: 210Table 4.: 210 -
Brief tale of a bacteraemia by Rhodococcus equi with concomitant lung mass: what came first, the chicken or the egg?
1421PDF: 827HTML: 8664Fig 3 Savini: 178Fig 2 Savini: 186Fig 1 Savini Chest TC: 191Author letter to referees: 191 -
HEPATITIS C VIRUS INFECTION AND LYMPHOMA
1020PDF: 555HTML: 7816 -
ATRA induced Reactive Hemophagocytosis: A Case Report
1248PDF: 605HTML: 2870ATRA induced Reactive Hemophagocytosis: A Case Report: 203 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2540PDF: 948HTML: 306 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1670PDF: 1250HTML: 266 -
Azacytidine failure revisited: an appraisal based on real life data from the MDS registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS). Azacytidine failure revisited
1105PDF: 860HTML: 253 -
CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH
1704PDF: 747HTML: 2347 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4094PDF: 1163HTML: 1971Fig.1: 219Fig. 2: 113Table 1: 207Table2: 225Table 3: 203 -
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
12412PDF: 1685HTML: 4214Cover letter: 205Figure 1: 213 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1581PDF: 1044HTML: 238 -
OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES
1293PDF: 1500Suppl. Files: 150HTML: 81







